{"company":{"id":3782835,"name":"Remepy","domain":"remepy.com","url":"https://alion.io/company/remepy"},"section":"news","answer":"Remepy: 40 headlines on record, 4 headlines in the last 90 days. Its story counts 4 milestones.","figures":[{"label":"Headlines","value":"40"},{"label":"In 90 days","value":"4"},{"label":"Milestones","value":"4"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":38},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":4}],"news":[{"date":"2026-09-29","kind":"News","title":"Hybridopa Shows Motor, Nonmotor Gains in Phase 2a Parkinson Disease Trial NeurologyLive - Clinical Neurology News and Neurology Expert Insights","source":"neurology live","url":"https://neurologylive.com/view/hybridopa-motor-nonmotor-gains-phase-2a-parkinson-disease-trial"},{"date":"2026-09-16","kind":"Press release","title":"Remepy Welcomes Pharma R&D Leader, Eran Harary, MD, as Chief Medical Officer, to Advance Hybrid Drug Pipeline","source":"PRNewswire","url":"https://prnewswire.com/news-releases/remepy-welcomes-pharma-rd-leader-eran-harary-md-as-chief-medical-officer-to-advance-hybrid-drug-pipeline-302880425.html"},{"date":"2026-09-16","kind":"News","title":"Remepy welcomes new CMO to advance hybrid drug pipeline","source":"thepharmaletter.com","url":"https://thepharmaletter.com/pharma-news/remepy-welcomes-new-cmo-to-advance-hybrid-drug-pipeline"},{"date":"2026-08-20","kind":"News","title":"Remepy Raises $36 Million Series A, Bringing Total Funding To $62 Million As Parkinson's Hybrid Drug Heads Toward Phase III","source":"Pulse 2.0","url":"https://pulse2.com/remepy-raises-36-million-series-a-bringing-total-funding-to-62-million-as-parkinsons-hybrid-drug-heads-toward-phase-iii/"},{"date":"2026-08-19","kind":"News","title":"August 19, 2026 Developer raises 36M, will help fund late-stage Parkinson's clinical trial Parkinson's News Today","source":"parkinsonsnewstoday.com","url":"https://parkinsonsnewstoday.com/news/developer-raises-36m-partly-funding-late-stage-parkinsons-clinical-trial/"},{"date":"2026-08-13","kind":"News","title":"Remepy Raises $36M to Advance Hybrid Drugs Into Phase III","source":"Tech Lens Media","url":"https://techlensmedia.com/news/remepy-raises-36m-to-advance-hybrid-drugs-into-phase-iii"},{"date":"2026-08-13","kind":"News","title":"Remepy secures $36m funding for Hybrid Drug pipeline expansion","source":"Pharmaceutical Technology","url":"https://pharmaceutical-technology.com/news/remepy-36m-funding-hybrid-drug-expansion/"},{"date":"2026-08-13","kind":"News","title":"August 13, 2026 Remepy raises US36m to advance Parkinson's treatment into Phase III Health Tech World","source":"htworld.co.uk","url":"https://htworld.co.uk/news/digital-health/remepy-raises-us-36-million-to-advance-parkinsons-treatment-into-phase-iii-mipo26/"},{"date":"2026-08-13","kind":"News","title":"August 13, 2026 Remepy raises 36m to take hybrid Parkinson's drug into Phase III The Pharma Letter","source":"thepharmaletter.com","url":"https://thepharmaletter.com/pharma-news/remepy-raises-36-million-to-take-hybrid-parkinsons-drug-into-phase-iii"},{"date":"2026-08-12","kind":"News","title":"Remepy Raises $36 Million Series A To Advance Hybridopa Phase III And Hybrid Drug Pipeline","source":"Pulse 2.0","url":"https://pulse2.com/remepy-raises-36-million-series-a-to-advance-hybridopa-phase-iii-and-hybrid-drug-pipeline/"},{"date":"2026-08-12","kind":"Press release","title":"Remepy Raises $36 Million Series A to Expand Its Hybrid Drug Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa for Parkinson","source":"PRNewswire","url":"https://prnewswire.com/news-releases/remepy-raises-36-million-series-a-to-expand-its-hybrid-drug-pipeline-through-pharmaceutical-partnerships-and-advance-phase-iii-of-hybridopa-for-parkinsons-disease-302849683.html"},{"date":"2026-08-12","kind":"News","title":"August 12, 2026 Remepy Raises 36.0M Series A for Hybrid Drugs Signal Base","source":"trysignalbase.com","url":"https://trysignalbase.com/news/funding/remepy-raises-36m-series-a-for-hybrid-drugs"},{"date":"2026-08-12","kind":"News","title":"August 12, 2026 Exclusive: Remepy raises 36M Series A for drug-software platform Axios","source":"axios.com","url":"https://axios.com/pro/biotech-deals/2026/08/12/remepy-36m-series-a-drug-software-platform"},{"date":"2026-08-12","kind":"News","title":"August 12, 2026 Remepy pockets 36M to push Parkinson's hybrid drug towards Phase III First Word Pharma","source":"firstwordpharma.com","url":"https://firstwordpharma.com/story/7843091"},{"date":"2026-08-12","kind":"News","title":"August 12, 2026 Remepy Secures 36 Million Series A to Advance Hybrid Drug Platform and Parkinson's Phase III Trial Tip Ranks","source":"tipranks.com","url":"https://tipranks.com/news/private-companies/remepy-secures-36-million-series-a-to-advance-hybrid-drug-platform-and-parkinsons-phase-iii-trial"},{"date":"2026-08-12","kind":"News","title":"August 12, 2026 Remepy Raises 36M in Series A Funding Finsmes","source":"finsmes.com","url":"https://finsmes.com/2026/08/remepy-raises-36m-in-series-a-funding.html"},{"date":"2026-08-12","kind":"News","title":"August 12, 2026 Hybrid Drug Pioneer Remepy Secures 36 Million in Series A Funding Startup Researcher","source":"startupresearcher.com","url":"https://startupresearcher.com/news/hybrid-drug-pioneer-remepy-secures-36-million-in-series-a-funding"},{"date":"2026-08-12","kind":"News","title":"One moment, please...","source":"jewishbreakingnews.com","url":"https://jewishbreakingnews.com/israeli-startups-ai-powered-treatment-shows-promising-results-against-parkinsons-raising-36-million-with-mercks-backing/"},{"date":"2026-07-28","kind":"News","title":"July 28, 2026 Training app paired with levodopa eases Parkinson's symptoms Parkinson's News Today","source":"parkinsonsnewstoday.com","url":"https://parkinsonsnewstoday.com/news/training-app-paired-levodopa-eases-parkinsons-symptoms/"},{"date":"2026-07-01","kind":"News","title":"Beyond the Pill: Remepy's Hybrid Drug Shows It Can Remodel Brain Networks - BriefGlance.com","source":"BriefGlance","url":"https://briefglance.com/articles/beyond-the-pill-remepys-hybrid-drug-shows-it-can-remodel-brain-networks"},{"date":"2026-07-01","kind":"Press release","title":"Remepy Publishes New Evidence Showing its Hybrid Drug, Hybridopa, Effect on Structural Connectivity in the Brain of Parkinson's Patients Associated with Improved Clinical ...","source":"morningstar.com","url":"https://morningstar.com/news/pr-newswire/20260701io96299/remepy-publishes-new-evidence-showing-its-hybrid-drug-hybridopa-effect-on-structural-connectivity-in-the-brain-of-parkinsons-patients-associated-with-improved-clinical-outcome"},{"date":"2026-06-26","kind":"News","title":"Local and global microstructural and functional thalamomotor connectivity alterations in Parkinson's disease following motor learning","source":"Nature","url":"https://nature.com/articles/s41531-026-01450-4?error=cookies_not_supported&amp;code=fdb2bd5d-95ec-4856-b67a-6ce913d087b2"},{"date":"2026-06-09","kind":"News","title":"Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson's","source":"Drug Discovery and Development","url":"https://drugdiscoverytrends.com/remepy-a-startup-that-pairs-drugs-with-ai-driven-apps-clears-a-phase-iia-test-in-parkinsons/"},{"date":"2026-05-21","kind":"News","title":"Remepy's app-drug combo heads for Phase III on mid-stage Parkinson's win","source":"Yahoo News","url":"https://yahoo.com/news/articles/remepy-app-drug-combo-heads-145814367.html"},{"date":"2026-05-21","kind":"News","title":"Remepy's hybrid Parkinson's therapy poised for phase 3","source":"pharmaphorum","url":"https://pharmaphorum.com/news/remepys-hybrid-parkinsons-therapy-poised-phase-3"},{"date":"2026-05-20","kind":"News","title":"May 20, 2026 Remepy posts strong Phase IIa results for Hybridopa The Pharma Letter","source":"thepharmaletter.com","url":"https://thepharmaletter.com/pharma-news/remepy-posts-strong-phase-iia-results-for-hybridopa"},{"date":"2026-05-03","kind":"News","title":"May 3, 2026 Merck KGaA taps into Remepy's Hybrid Drug platform The Pharma Letter","source":"thepharmaletter.com","url":"https://thepharmaletter.com/pharma-news/merck-kgaa-taps-into-remepy-s-hybrid-drug-platform"},{"date":"2026-04-29","kind":"News","title":"April 29, 2026 Remepy, Merck KGaA pair up to test app-paired drug model in rare tumour FirstWord Pharma","source":"firstwordpharma.com","url":"https://firstwordpharma.com/story/7233714"},{"date":"2026-04-28","kind":"News","title":"Merck KGaA and Remepy join forces to develop combo drug-digital therapies","source":"YahooFinance","url":"https://finance.yahoo.com/sectors/healthcare/articles/merck-kgaa-remepy-join-forces-120025185.html"},{"date":"2026-04-28","kind":"News","title":"April 28, 2026 Remepy to Collaborate with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas American Pharmaceutical Review","source":"americanpharmaceuticalreview.com","url":"https://americanpharmaceuticalreview.com/1315-News/625393-Remepy-to-Collaborate-with-Merck-KGaA-Darmstadt-Germany-to-Advance-Hybrid-Drugs-Across-Therapeutic-Areas/"},{"date":"2026-04-28","kind":"News","title":"April 28, 2026 Merck KGaA, Remepy team up on software-enhanced hybrid drugs for rare tumors Fierce Biotech","source":"fiercebiotech.com","url":"https://fiercebiotech.com/medtech/merck-kgaa-remepy-team-software-enhanced-hybrid-drugs-rare-tumors"},{"date":"2025-06-14","kind":"News","title":"Mobile application leads to psychological improvement and correlated neuroimmune function change in subjective cognitive decline","source":"Nature","url":"https://nature.com/articles/s41746-025-01765-1?error=cookies_not_supported&amp;code=ef41dd08-eab0-4b84-8b53-db495f9dfb67"},{"date":"2025-02-26","kind":"News","title":"Brain connectivity correlates of the impact of a digital intervention for individuals with subjective cognitive decline on depression and IL-18","source":"Nature","url":"https://nature.com/articles/s41598-025-91457-3?error=cookies_not_supported&amp;code=5080eb09-d252-49b5-afc5-abbf18de360c"},{"date":"2024-06-06","kind":"News","title":"June 6, 2024 Israeli Startup Combines Software With Medicine To Transform 1.6 Trillion Pharma Market Forbes","source":"forbes.com","url":"https://forbes.com/sites/gilpress/2024/06/06/israeli-startup-combines-software-with-medicine-to-transform-16-trillion-pharma-market/?sh=3baa90ea58f1"},{"date":"2024-05-01","kind":"Press release","title":"May 1, 2024 Remepy Launches with 15 Million in Funding To Bring First Hybrid Drug To Market Business Wire","source":"businesswire.com","url":"https://businesswire.com/news/home/20240501687531/en/Remepy-Launches-with-%2415-Million-in-Funding-To-Bring-First-Hybrid-Drug-To-Market"},{"date":"2024-04-30","kind":"Press release","title":"Remepy Launches with $15 Million in Funding To Bring First Hybrid Drug To Market","source":"businesswire.com","url":"https://businesswire.com/news/home/20240501687531/en/Remepy-Launches-with-15-Million-in-Funding-To-Bring-First-Hybrid-Drug-To-Market"},{"date":"2024-02-14","kind":"News","title":"Naftali Bennett joins board of Israeli biotech co","source":"Globes","url":"https://en.globes.co.il/en/article-naftali-bennett-joins-board-of-israeli-biotech-co-1001471212"},{"kind":"News","title":"Brain Communications","source":"academic.oup.com","url":"https://academic.oup.com/braincomms/article/8/3/fcag148/8684910"}],"story":[{"title":"New executive Remepy welcomes new CMO to advance hybrid drug pipeline · thepharmaletter.com","url":"https://thepharmaletter.com/pharma-news/remepy-welcomes-new-cmo-to-advance-hybrid-drug-pipeline"},{"title":"Raised a round Series A $36M","url":"https://axios.com/pro/biotech-deals/2026/08/12/remepy-36m-series-a-drug-software-platform"},{"title":"Partnership Merck KGaA and Remepy join forces to develop combo drug-digital therapies · YahooFinance","url":"https://finance.yahoo.com/sectors/healthcare/articles/merck-kgaa-remepy-join-forces-120025185.html"},{"title":"Website went live first capture in the Wayback Machine","url":"https://web.archive.org/web/20230129152054/remepy.com"}],"as_of":"2026-11-17","cite":"Remepy, News. Alion, Nov 17, 2026. https://alion.io/company/remepy/news","html_url":"https://alion.io/company/remepy/news","json_url":"https://alion.io/company/remepy/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T19:47:59Z"}}